| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Performance Stock Units | 177,865 | $1.08 M | $6.07 | Jan 27, 2024 | Direct |
| SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Restricted Stock Units | 167,707 | $1.02 M | $6.07 | Jan 27, 2024 | Direct |
| SIGA TECHNOLOGIES INC | Chief Executive Officer, Director | Stock Option (Right to buy) | 219,212 | Jan 27, 2024 | Direct | ||
| Verrica Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 20,000 | Jun 6, 2024 | Direct | ||
| Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,240 | Jun 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Jun 26, 2024 | 1 | 0 | 4 | Jun 27, 2024 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 6, 2024 | 1 | 0 | 4 | Jun 7, 2024 | Director |
| SIGA | SIGA TECHNOLOGIES INC | Jan 27, 2024 | 4 | 0 | 4 | Jan 30, 2024 | Chief Executive Officer, Director |
| SIGA | SIGA TECHNOLOGIES INC | Jan 27, 2024 | 0 | 0 | 3 | Jan 30, 2024 | Chief Executive Officer, Director |
| CADL | Candel Therapeutics, Inc. | Jun 28, 2023 | 1 | 0 | 4 | Jun 29, 2023 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 8, 2023 | 1 | 0 | 4 | Jun 12, 2023 | Director |
| CADL | Candel Therapeutics, Inc. | Oct 13, 2022 | 1 | 0 | 4 | Oct 17, 2022 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 9, 2022 | 1 | 0 | 4 | Jun 13, 2022 | Director |
| CADL | Candel Therapeutics, Inc. | Dec 31, 2021 | 1 | 0 | 5/A | Feb 14, 2022 | Director |
| CADL | Candel Therapeutics, Inc. | Jul 29, 2021 | 1 | 80,000 | 4 | Aug 2, 2021 | Director |
| CADL | Candel Therapeutics, Inc. | Jul 26, 2021 | 0 | 0 | 3 | Jul 26, 2021 | Director |
| VRCA | Verrica Pharmaceuticals Inc. | Jun 10, 2021 | 1 | 0 | 4/A | Jun 17, 2021 | Director |